BQ-123 - 98%, high purity , CAS No.136553-81-6, Antagonist of ET A receptor

Item Number
B275090
Grouped product items
SKUSizeAvailabilityPrice Qty
B275090-1mg
1mg
Available within 8-12 weeks(?)
Production requires sourcing of materials. We appreciate your patience and understanding.
$99.90
B275090-5mg
5mg
3
$395.90
B275090-10mg
10mg
2
$692.90
B275090-25mg
25mg
2
$1,559.90
B275090-50mg
50mg
2
$2,806.90
B275090-100mg
100mg
2
$5,051.90

Potent, selective ET A receptor antagonist

Basic Description

Synonyms2-((3R,6S,9R,12R,17aS)-9-((1H-indol-3-yl)methyl)-6-isobutyl-3-isopropyl-1,4,7,10,13-pentaoxohexadecahydro-1H-pyrrolo[1,2-a][1,4,7,10,13]pentaazacyclopentadecin-12-yl)acetic acid | cyclo(L-Leu-D-Trp-D-Asp-L-Pro-D-Val) | BDBM50197954 | LS-13503 | B-186 | BQ
Specifications & PurityMoligand™, ≥98%
Biochemical and Physiological MechanismsPotent, selective ET A receptor antagonist (IC 50 values are 7.3 and 18,000 nM for ET A and ET B endothelin receptors respectively). Some ability to cross the blood-brain barrier. Anti-ischemic activity in vivo .
Storage TempStore at -20°C,Desiccated
Shipped InIce chest + Ice pads
GradeMoligand™
Action TypeANTAGONIST
Mechanism of actionAntagonist of ET A receptor
NoteWherever possible, you should prepare and use solutions on the same day. However, if you need to make up stock solutions in advance, we recommend that you store the solution as aliquots in tightly sealed vials at -20°C. Generally, these will be useable for up to one week. Before use, and prior to opening the vial we recommend that you allow your product to equilibrate to room temperature for at least 1 hour. Need more advice on solubility, usage and handling? Please visit our frequently asked questions (FAQ) page for more details.

AI Insight

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Names and Identifiers

Pubchem Sid504758796
Pubchem Sid Urlhttps://pubchem.ncbi.nlm.nih.gov/substance/504758796
IUPAC Name 2-[(3R,6R,9S,12R,15S)-6-(1H-indol-3-ylmethyl)-9-(2-methylpropyl)-2,5,8,11,14-pentaoxo-12-propan-2-yl-1,4,7,10,13-pentazabicyclo[13.3.0]octadecan-3-yl]acetic acid
INCHI InChI=1S/C31H42N6O7/c1-16(2)12-21-27(40)33-22(13-18-15-32-20-9-6-5-8-19(18)20)28(41)35-23(14-25(38)39)31(44)37-11-7-10-24(37)29(42)36-26(17(3)4)30(43)34-21/h5-6,8-9,15-17,21-24,26,32H,7,10-14H2,1-4H3,(H,33,40)(H,34,43)(H,35,41)(H,36,42)(H,38,39)/t21-,22+,23+,24-,26+/m0/s1
InChi Key VYCMAAOURFJIHD-PJNXIOHISA-N
Canonical SMILES CC(C)CC1C(=O)NC(C(=O)NC(C(=O)N2CCCC2C(=O)NC(C(=O)N1)C(C)C)CC(=O)O)CC3=CNC4=CC=CC=C43
Isomeric SMILES CC(C)C[C@H]1C(=O)N[C@@H](C(=O)N[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](C(=O)N1)C(C)C)CC(=O)O)CC3=CNC4=CC=CC=C43
PubChem CID 443289
Molecular Weight 610.7

Certificates(CoA,COO,BSE/TSE and Analysis Chart)

C of A & Other Certificates(BSE/TSE, COO):
Analytical Chart:

Find and download the COA for your product by matching the lot number on the packaging.

6 results found

Lot NumberCertificate TypeDateItem
K2218158Certificate of AnalysisAug 25, 2022 B275090
K2218163Certificate of AnalysisAug 25, 2022 B275090
K2218171Certificate of AnalysisAug 25, 2022 B275090
K2218172Certificate of AnalysisAug 25, 2022 B275090
K2218174Certificate of AnalysisAug 25, 2022 B275090
K2218188Certificate of AnalysisAug 25, 2022 B275090

Related Documents

Reviews

Customer Reviews

References

1. Maayah ZH et al..  (2020)  Breast cancer diagnosis is associated with relative left ventricular hypertrophy and elevated endothelin-1 signaling..  BMC Cancer,  20  (751).  [PMID:32787791]
2. Wu Q et al..  (2018)  CT perfusion imaging of cerebral microcirculatory changes following subarachnoid hemorrhage in rabbits: Specific role of endothelin-1 receptor antagonist..  Brain Res,  1701  (196-203).  [PMID:30244111]
3. Kobayashi Y et al..  (2021)  Early manifestations and differential gene expression associated with photoreceptor degeneration in Prom1-deficient retina..  Dis Model Mech,  14  (11):   [PMID:34664634]
4. Furukawa A et al..  (2018)  Endothelin Signaling Contributes to Modulation of Nociception in Early-stage Tongue Cancer in Rats..  Anesthesiology,  128  (6): (1207-1219).  [PMID:29461271]

Solution Calculators